Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108 USD | +1.81% |
|
+5.65% | -12.19% |
07-10 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
07-09 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.19% | 6.81B | |
+55.35% | 815B | |
+32.43% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.26% | 247B | |
+14.45% | 228B | |
+16.54% | 180B | |
+4.31% | 170B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Jazz Pharmaceuticals plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 03